The AMN Healthcare Services, Inc. (NYSE: AMN) SEC filings page brings together the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents provide detailed information on AMN Healthcare’s financial condition, capital structure, governance and material events affecting its healthcare workforce solutions and staffing business.
Through periodic and current reports, investors can review how AMN Healthcare’s three reportable segments—Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions—contribute to its overall performance. Filings such as annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) typically include segment discussions, risk factors, management’s analysis and notes on non-GAAP measures like adjusted EBITDA and adjusted diluted EPS.
Current reports on Form 8-K highlight specific events, including earnings announcements, senior notes offerings, amendments to the company’s credit agreement, and changes to its by-laws. For example, AMN Healthcare has filed 8-Ks describing the issuance of senior notes due 2031, amendments to its secured revolving credit facility, and the adoption of amended and restated by-laws that align with developments in Delaware law and update stockholder meeting procedures.
On this page, users can also access filings related to capital markets activities and other material agreements, which explain the terms of AMN Healthcare’s debt instruments and covenants. These disclosures help investors understand the company’s leverage, maturity profiles and financial flexibility.
Stock Titan enhances access to these filings with AI-powered summaries that explain key points in plain language. Users can quickly see the main implications of lengthy documents, such as how a new notes offering affects the balance sheet or how governance changes may influence stockholder rights, while still having the option to review the full SEC filings.
AMN Healthcare Services reported a sharp turnaround in Q1 2026, driven by large labor disruption projects. Revenue doubled to $1,378.4 million from $689.5 million, led by nurse and allied solutions, which surged to $1,127.3 million as AMN staffed multiple large-scale labor disruption events.
Net income swung to a profit of $62.2 million, or $1.60 per basic share, compared with a small loss a year earlier. Operating cash flow jumped to $562.5 million, reflecting sizable client deposits and higher segment operating income, and cash and cash equivalents rose to $560.7 million with the revolving credit facility fully repaid.
While nurse and allied solutions grew 173%, physician and leadership solutions revenue declined 6% and technology and workforce solutions fell 15%, pressured by lower locum tenens volume, weaker VMS and language pricing, and the sale of the Smart Square scheduling software. Consolidated gross margin narrowed to 26.8% from 28.7% as mix shifted and technology margins compressed, partly offset by higher-margin labor disruption work.
AMN Healthcare Services reported a very strong first quarter of 2026, with revenue of $1.378 billion, up 100% from a year earlier, and net income of $62 million or $1.59 per diluted share versus a prior-year loss. Adjusted diluted EPS rose to $2.10 from $0.45, while adjusted EBITDA reached $166.1 million, a 159% increase and a 12.1% margin. Nurse and Allied Solutions revenue grew to $1.127 billion, helped by $722 million from labor disruption events, and most staffing categories showed year-over-year growth, though Physician and Leadership Solutions and Technology and Workforce Solutions declined.
Cash flow from operations was $562 million, boosting cash to $561 million against $750 million of debt and a 1.6x leverage ratio. For second quarter 2026, AMN guided consolidated revenue to $620–$635 million with operating margin around breakeven and adjusted EBITDA margin of 6.7%–7.2%, signaling a step-down from the disruption-driven Q1 peak.
Palmer Eric P reported acquisition or exercise transactions in this Form 4 filing.
AMN Healthcare Services director Eric P. Palmer received a grant of 8,304 restricted stock units (RSUs). The award was made on May 1, 2026 under the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN common stock at vesting.
The 8,304 RSUs vest on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual Meeting of Shareholders. Restricted stock units do not have an expiration date, and Palmer’s direct holdings of RSUs following this grant total 8,304 units.
Hinton James H. reported acquisition or exercise transactions in this Form 4 filing.
AMN Healthcare Services director James H. Hinton received an equity award of 8,304 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of AMN common stock under the AMN Healthcare 2025 Equity Plan.
The RSUs were granted on May 1, 2026 and vest on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual Meeting of Shareholders. At Hinton’s irrevocable election, the vested RSUs will settle in shares on the date he separates from service as a director.
Fontenot Teri G. reported acquisition or exercise transactions in this Form 4 filing.
AMN Healthcare Services director Teri G. Fontenot received a grant of 8,304 Restricted Stock Units as equity compensation. Each RSU represents a right to one share of AMN common stock. The RSUs vest on the earlier of one year from the May 1, 2026 grant date or the 2027 Annual Meeting of Shareholders, and settle upon the director's separation from service, based on her prior election.
AMN Healthcare Services director Jeffrey R. Harris acquired additional common shares through the vesting and settlement of Restricted Stock Units (RSUs). On May 1, 2026, RSU awards converted into a total of 43,063 shares of AMN common stock, with no open‑market purchases or sales reported.
The RSUs were granted under AMN equity plans, including awards from 2006–2010 and a 2025 grant. Several older RSU grants settled on May 1, 2026, which the footnotes identify as the date of the director's separation from service with the company. Following these settlements, Harris holds 67,262 shares of AMN common stock directly.
AMN Healthcare Services director Sylvia Trent-Adams reported routine equity compensation changes. On May 1, 2026, 8,325 shares of common stock were acquired upon vesting and exercise of previously granted Restricted Stock Units (RSUs) under the AMN Healthcare 2017 Equity Plan, bringing her direct common stock holdings to 16,797 shares after the transaction. The filing also shows a new grant of 8,304 RSUs under the AMN Healthcare 2025 Equity Plan, each representing one future share of common stock. These new RSUs vest on the earlier of the one-year anniversary of the May 1, 2026 grant date or the company’s 2027 Annual Meeting of Shareholders.
Jones Daphne E reported acquisition or exercise transactions in this Form 4 filing.
AMN Healthcare Services director Daphne E. Jones reported routine equity compensation activity. On May 1, 2026, 8,325 Restricted Stock Units (RSUs) vested and settled into 8,325 shares of AMN common stock, increasing her direct common stock holdings to 17,124 shares.
On the same date, she received a new grant of 8,304 RSUs under the AMN Healthcare 2025 Equity Plan. Each RSU represents a right to receive one share of common stock and will vest on the earlier of the one-year anniversary of the grant or the company’s 2027 annual shareholder meeting, with settlement at her separation from service.
AMN Healthcare Services director Mark G. Foletta reported routine equity compensation activity. He acquired 8,325 shares of Common Stock through the vesting and exercise of Restricted Stock Units (RSUs), bringing his direct Common Stock holdings to 21,598 shares.
He also received a new grant of 8,304 RSUs, each representing a contingent right to one share of AMN Common Stock. According to the footnotes, these RSUs were granted on May 1, 2026 under the AMN Healthcare 2025 Equity Plan and vest on the earlier of one year after the grant date or the company’s 2027 Annual Meeting of Shareholders.
AMN Healthcare Services director Jorge A. Caballero reported compensation-related equity activity. On May 1, 2026, he exercised 8,325 Restricted Stock Units (RSUs), receiving the same number of AMN common shares, bringing his direct common stock holdings to 15,462 shares.
On the same date, he received a new award of 8,304 RSUs under the AMN Healthcare 2025 Equity Plan, each representing one share of common stock upon vesting. The filing shows no share sales; activity consists of an RSU vesting/exercise and a new RSU grant tied to board service.